RFX7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.342000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.340400E-01
Normal-vs-Stage2
3.393800E-01
Normal-vs-Stage3
1.991970E-01
Normal-vs-Stage4
2.454400E-01
Stage1-vs-Stage2
3.438200E-01
Stage1-vs-Stage3
4.462400E-03
Stage1-vs-Stage4
5.302800E-01
Stage2-vs-Stage3
<1E-12
Stage2-vs-Stage4
9.279000E-01
Stage3-vs-Stage4
1.352370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.324800E-01
Normal-vs-AfricanAmerican
2.782800E-01
Normal-vs-Asian
2.735800E-01
Caucasian-vs-AfricanAmerican
2.241200E-01
Caucasian-vs-Asian
2.074400E-01
AfricanAmerican-vs-Asian
1.157440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.294800E-01
Normal-vs-Female
3.409400E-01
Male-vs-Female
6.990400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.792600E-01
Normal-vs-Age(41-60Yrs)
3.773200E-01
Normal-vs-Age(61-80Yrs)
3.168400E-01
Normal-vs-Age(81-100Yrs)
3.067000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.936600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.066600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.115000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.591700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.330200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.085200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.955800E-01
Normal-vs-Daily Drinker
2.823800E-01
Normal-vs-Weekly Drinker
2.777200E-01
Normal-vs-Occasional Drinker
3.699200E-01
Normal-vs-Social Drinker
3.567600E-01
Non Drinker-vs-Daily Drinker
7.341800E-01
Non Drinker-vs-Weekly Drinker
6.660600E-01
Non Drinker-vs-Occasional Drinker
1.827190E-01
Non Drinker-vs-Social Drinker
3.235000E-01
Daily Drinker-vs-Weekly Drinker
9.050200E-01
Daily Drinker-vs-Occasional Drinker
1.367770E-01
Daily Drinker-vs-Social Drinker
2.495600E-01
Weekly Drinker-vs-Occasional Drinker
1.476010E-01
Weekly Drinker-vs-Social Drinker
2.566200E-01
Occasional Drinker-vs-Social Drinker
8.458400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.152820E-01
Normal-vs-Grade 2
4.028400E-02
Normal-vs-Grade 3
2.396200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.079000E-01
Grade 1-vs-Grade 3
2.106800E-01
Grade 1-vs-Grade 4
1.152820E-01
Grade 2-vs-Grade 3
2.608400E-01
Grade 2-vs-Grade 4
4.028400E-02
Grade 3-vs-Grade 4
2.396200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.980000E-01
Normal-vs-NonDiabetic
3.194000E-01
Diabetic-vs-NonDiabetic
4.491600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.971200E-01
Normal-vs-NoPancreatitis
3.207600E-01
Pancreatitis-vs-NoPancreatitis
5.457000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.195000E-01
Normal-vs-N1
3.457200E-01
N0-vs-N1
3.925000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.854400E-01
Normal-vs-TP53-NonMutant
4.109200E-01
TP53-Mutant-vs-TP53-NonMutant
6.132000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
